Although recent efforts have been aimed at understanding the contribution of cav-1 toward tumor growth, it remains unknown whether the loss of cav-1 is associated with alterations in the stromal architecture of the gland, a phenomenon that has been extensively reported to accompany breast tumor progression. Here, CAV1 is linked to neoplasm.